WY 45911
Latest Information Update: 26 Jun 1998
At a glance
- Originator Wyeth
- Class Antiasthmatics
- Mechanism of Action Leukotriene receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma